These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 39307762)
1. [Guidelines for construction of traditional Chinese medicine pharmacovigilance system in medical institutions]. Liu FM; Zhang L; Li YY; Wang ZF; Zhao XX; Cui X; Wei RL; Yang S; Wang LX; Xie YM Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4266-4272. PubMed ID: 39307762 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacovigilance guidelines for clinical application of Chinese patent medicines for mucosal administration]. Zhao XX; Hua H; Li YY; Wang ZF; Liu FM; Wei RL; Cui X; Yang S; Wang LX; Xie YM Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4291-4297. PubMed ID: 39307766 [TBL] [Abstract][Full Text] [Related]
3. [Pharmacovigilance guidelines of Chinese patent medicines]. Wang LX; Wang MM; Li YY; Wang ZF; Cui X; Zhao XX; Liu FM; Yang S; Wei RL; Wang YX; Zhang B; Xie YM Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4261-4265. PubMed ID: 39307761 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacovigilance guidelines for clinical application of oral Chinese patent medicines]. Wang LX; Yang S; Wei RL; Li YY; Cui X; Zhao XX; Peng WX; Liu FM; Wang MM; Li XH; Wang ZF; Xie YM Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4273-4278. PubMed ID: 39307763 [TBL] [Abstract][Full Text] [Related]
5. [Pharmacovigilance guidelines for clinical application of Chinese patent medicines for external use]. Cui X; Yang DQ; Xie ZN; Li YY; Wang ZF; Liu H; Liu FM; Zhao XX; Lu ZK; Wang LX; Xie YM Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4285-4290. PubMed ID: 39307765 [TBL] [Abstract][Full Text] [Related]
6. [Pharmacovigilance guidelines for clinical application of traditional Chinese medicine injections]. Fu CK; Liu H; Wang LX; Zou YH; Li MQ; Lin YM; Sun WH; Wei X; Hu YE; Xie YM; Li YY Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4279-4284. PubMed ID: 39307764 [TBL] [Abstract][Full Text] [Related]
7. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective. Zhang L; Yan J; Liu X; Ye Z; Yang X; Meyboom R; Chan K; Shaw D; Duez P J Ethnopharmacol; 2012 Apr; 140(3):519-25. PubMed ID: 22374080 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacovigilance of Chinese medicine: practice of cognition, application, prevention and rescue of drug toxicity]. Zhang B; Lin ZJ; Zhang XM Zhongguo Zhong Yao Za Zhi; 2017 May; 42(10):2017-2020. PubMed ID: 29090566 [TBL] [Abstract][Full Text] [Related]
9. Traditional Chinese medicine and drug-induced anaphylaxis: data from the Beijing pharmacovigilance database. Li X; Thai S; Lu W; Sun S; Tang H; Zhai S; Wang T Int J Clin Pharm; 2018 Aug; 40(4):921-927. PubMed ID: 30051226 [TBL] [Abstract][Full Text] [Related]
10. [Interpretation of Technical Specifications for Revision of Safety Information in Marketed Chinese Patent Medicine Instructions]. Zhang XM; Lin ZJ; Zhang B; Sa RN; Lyu JT; Wu H; Li YL; Xu HZ; Huang ZK; Guo YB; Su XF; Duan XJ Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):295-300. PubMed ID: 35178970 [TBL] [Abstract][Full Text] [Related]
11. [Guidelines for quality control of human use experience study on traditional Chinese medicine]. Tang YQ; Yang ZQ; Tang ZA; Yuan WA; Tang JY; Zou C Zhongguo Zhong Yao Za Zhi; 2024 Sep; 49(17):4801-4804. PubMed ID: 39307814 [TBL] [Abstract][Full Text] [Related]
12. Traditional Chinese medicine research in the post-genomic era: good practice, priorities, challenges and opportunities. Uzuner H; Bauer R; Fan TP; Guo DA; Dias A; El-Nezami H; Efferth T; Williamson EM; Heinrich M; Robinson N; Hylands PJ; Hendry BM; Cheng YC; Xu Q J Ethnopharmacol; 2012 Apr; 140(3):458-68. PubMed ID: 22387462 [TBL] [Abstract][Full Text] [Related]
13. Tailored to fit: China optimizes policies and regulations regarding drug registration and review to promote innovation in traditional Chinese medicine. Lu D; Dou F; Qi F; Gao J Drug Discov Ther; 2024 Sep; 18(4):210-212. PubMed ID: 39034115 [TBL] [Abstract][Full Text] [Related]
14. [Discussion on establishment of quality control system for intensive hospital monitoring on traditional Chinese medicine injections]. Jiang JJ; Xie YM Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2689-91. PubMed ID: 23285909 [TBL] [Abstract][Full Text] [Related]
15. [Clinical centralized safety monitoring and evaluation of traditional Chinese medicine formula granules]. Wu CF; Liao JB; Li D; Yang ML; Chen QZ; Yang ZQ Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(15):4231-4236. PubMed ID: 37802791 [TBL] [Abstract][Full Text] [Related]
16. [Research on establishment of clinical safety intensive hospital monitoring net of traditional Chinese medicine injection]. Wang LX; Xie YM; Wang ZF Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2692-4. PubMed ID: 23285910 [TBL] [Abstract][Full Text] [Related]
17. Adverse drug reaction reporting in institutions across six Chinese provinces: a cross-sectional study. Zhang X; Niu R; Feng B; Guo J; Liu Y; Liu X Expert Opin Drug Saf; 2019 Jan; 18(1):59-68. PubMed ID: 29883236 [TBL] [Abstract][Full Text] [Related]
18. [Urgent need for medical institutions to develop traditional Chinese medicine decoction pieces prescription-based processing and related suggestions]. Li XR; Wei F; Cao H Zhongguo Zhong Yao Za Zhi; 2021 Sep; 46(17):4585-4590. PubMed ID: 34581066 [TBL] [Abstract][Full Text] [Related]
19. [Enlightenment of international pharmacovigilance system on establishment of pharmacovigilance system of Chinese medicine]. Cui X; Wang LX; Liu GY; Xie YM Zhongguo Zhong Yao Za Zhi; 2021 Nov; 46(21):5450-5455. PubMed ID: 34951195 [TBL] [Abstract][Full Text] [Related]
20. [Traditional Chinese medicine preparations in medical institutions: current situation and inspirations on research and development of new traditional Chinese medicine preparations]. Ma ZM; Ouyang H; Ni J; Lyu Z; Li H Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1415-1420. PubMed ID: 38621990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]